| 摘要: |
| 血液透析是急慢性肾衰竭患者治疗的一种有效手段,其中血液透析浓缩物作为透析重要组成部分,它的质量对透析效果产生重要影响。本文就中美药典中对血液透析浓缩物中部分相关物质要求进行比较,并对相关药典修订提出建议,为相关药典制定及相关领域专业人士参考使用。 |
| 关键词: 药典 血液透析浓缩物 比较 |
| DOI:10.13506/j.cnki.jpr.2018.10.015 |
| 基金项目: |
|
|
|
| Comparison of requirements between Chinese and American pharmacopoeia for related substances in hemodialysis concentrate |
| YE Chenghong,YANG Yuxi,KE Linnan |
| (1. Center For Medical Device Evaluation ,CFDA, Beijing 100081,China;2.National Institutes for Food and Drug Control,Beijing 102269,China) |
| Abstract: |
| Hemodialysis is an effective way to treat patients with acute and chronic renal failure.As a part of hemodialysis,the quality of hemodialysis concentrate has an important impact on the safty and effectiveness of dialysis. In this paper, the requirements of some related substances in hemodialysis concentrates in Chinese and American Pharmacopoeia were compared for reference by professionals in pharmacopoeia formulation and related fields. |
| Key words: Pharmacopoeia hemodialysis concentrate Comparison |